Build, discover and catalyse

BioTrinity, now in its 13th year, is Europe’s leading Biopartnering and Investment conference, and generates unrivalled opportunities for life science companies, academics, investors, and major pharmaceutical players to come together to do deals and establish collaborations.

BioTrinity 2019 incorporates significant improvements including a move to etc.venues 155 Bishopsgate, a central London location.  This new venue allows us to keep all activity on one floor which will focus the energy and facilitate interaction, thereby maximising visibility for our sponsors, exhibitors, BioLaunchPad® presenters and creating even more opportunities for networking and informal meetings.

The focus of the 2019 conference is to look at 'What’s new' in the industry, and we’ll be providing updates and insight on both technical and financial developments across a wide range of key therapeutics areas – have a look at the Draft Programme.

-->

BioTrinity 2018 Highlights

Delegates 860
Companies >450
Representatives from investment firms 150
Representatives from global pharma 75
One-to-One partnering meetings scheduled >2000
Countries represented 27